555 related articles for article (PubMed ID: 28161874)
1. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up.
Grazzi L; Sansone E; Raggi A; D'Amico D; De Giorgio A; Leonardi M; De Torres L; Salgado-García F; Andrasik F
J Headache Pain; 2017 Dec; 18(1):15. PubMed ID: 28161874
[TBL] [Abstract][Full Text] [Related]
2. A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache.
Grazzi L; Raggi A; D'Amico D; Sansone E; Leonardi M; Andrasik F; Gucciardi A; Guido D; D'Andrea G
Cephalalgia; 2019 Apr; 39(5):655-664. PubMed ID: 30213202
[TBL] [Abstract][Full Text] [Related]
3. Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal.
Grazzi L; D'Amico D; Raggi A; Leonardi M; Ciusani E; Corsini E; D'Andrea G; Bolner A; Salgado-García F; Andrasik F; Sansone E
Neurol Sci; 2017 May; 38(Suppl 1):173-175. PubMed ID: 28527073
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study).
Grazzi L; D'Amico D; Guastafierro E; Demichelis G; Erbetta A; Fedeli D; Nigri A; Ciusani E; Barbara C; Raggi A
J Headache Pain; 2023 Jul; 24(1):86. PubMed ID: 37452281
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
7. Psychological variables in chronic migraine with medication overuse before and after inpatient withdrawal: results at 1-year follow-up.
Usai S; Grazzi L; D'Amico D; Andrasik F; Bussone G
Neurol Sci; 2009 May; 30 Suppl 1():S125-7. PubMed ID: 19415442
[TBL] [Abstract][Full Text] [Related]
8. Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients.
Curone M; Tullo V; Didier HA; Bussone G
Neurol Sci; 2022 Sep; 43(9):5759-5761. PubMed ID: 35836032
[TBL] [Abstract][Full Text] [Related]
9. Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study.
Raggi A; Giovannetti AM; Leonardi M; Sansone E; Schiavolin S; Curone M; Grazzi L; Usai S; D'Amico D
Headache; 2017 Jan; 57(1):60-70. PubMed ID: 27861823
[TBL] [Abstract][Full Text] [Related]
10. A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache.
Grazzi L; Raggi A; Guastafierro E; Passavanti M; Marcassoli A; Montisano DA; D'Amico D
Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360996
[TBL] [Abstract][Full Text] [Related]
11. Treatment of medication overuse headache: Effect and predictors after 1 year-A randomized controlled trial.
Carlsen LN; Rouw C; Westergaard ML; Nielsen M; Munksgaard SB; Bendtsen L; Jensen RH
Headache; 2021 Jul; 61(7):1112-1122. PubMed ID: 34325483
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
[TBL] [Abstract][Full Text] [Related]
13. Behavioral plus pharmacological treatment versus pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal.
Grazzi L; Usai S; Prunesti A; Bussone G; Andrasik F
Neurol Sci; 2009 May; 30 Suppl 1():S117-9. PubMed ID: 19415440
[TBL] [Abstract][Full Text] [Related]
14. Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.
Seng EK; Singer AB; Metts C; Grinberg AS; Patel ZS; Marzouk M; Rosenberg L; Day M; Minen MT; Lipton RB; Buse DC
Headache; 2019 Oct; 59(9):1448-1467. PubMed ID: 31557329
[TBL] [Abstract][Full Text] [Related]
15. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
Headache; 2004; 44(7):678-83. PubMed ID: 15209690
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study).
Fedeli D; Ciullo G; Demichelis G; Medina Carrion JP; Bruzzone MG; Ciusani E; Erbetta A; Ferraro S; Grisoli M; Guastafierro E; D'Amico D; Raggi A; Nigri A; Grazzi L
J Headache Pain; 2024 Jun; 25(1):97. PubMed ID: 38858629
[TBL] [Abstract][Full Text] [Related]
17. Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application.
Diener HC; Donoghue S; Gaul C; Holle-Lee D; Jöckel KH; Mian A; Schröder B; Kühl T
Trials; 2022 May; 23(1):382. PubMed ID: 35546412
[TBL] [Abstract][Full Text] [Related]
18. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial.
Engelstoft IMS; Carlsen LN; Munksgaard SB; Nielsen M; Jensen RH; Bendtsen L
Eur J Pain; 2019 Jul; 23(6):1162-1170. PubMed ID: 30793412
[TBL] [Abstract][Full Text] [Related]
19. No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: A double blind, randomised clinical trial.
Grazzi L; Usai S; Bolognini N; Grignani E; Sansone E; Tramacere I; Maravita A; Lauria G
Cephalalgia; 2020 Oct; 40(11):1202-1211. PubMed ID: 32536270
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal failure in patients with chronic migraine and medication overuse headache.
D'Amico D; Grazzi L; Guastafierro E; Sansone E; Leonardi M; Raggi A
Acta Neurol Scand; 2021 Oct; 144(4):408-417. PubMed ID: 34036572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
